ASND Quote, Trading Chart, Ascendis Pharma A/S
home / stock / asnd / asnd quote
$88.79 Last:
0.08% Change Percent:
$89.34 Open:
$88.79 Previous Close:
$89.34 High:
$83.35 Low:
476,582 Volume:
05/27/2022 04:53:26 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
ASND Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2022-05-27 | 89.34 | 88.79 | 89.34 | 83.35 | 476,582 |
| 2022-05-26 | 90.54 | 88.72 | 92.475 | 88.01 | 451,658 |
| 2022-05-25 | 90 | 90.3 | 92.19 | 88.1 | 215,838 |
| 2022-05-24 | 95.69 | 90.5 | 95.69 | 89.86 | 360,611 |
| 2022-05-23 | 95.53 | 97.01 | 98.11 | 93.4539 | 403,874 |
| 2022-05-20 | 92.72 | 95.4 | 95.63 | 90.02 | 420,579 |
| 2022-05-19 | 86.16 | 91.13 | 91.29 | 85 | 538,404 |
| 2022-05-18 | 87.42 | 86 | 89.44 | 85.34 | 425,730 |
| 2022-05-17 | 86.06 | 88.97 | 90.93 | 85.03 | 459,039 |
| 2022-05-16 | 83.12 | 84.73 | 85.45 | 82.62 | 661,757 |
| 2022-05-13 | 80.51 | 83.12 | 85.95 | 79.355 | 1,173,517 |
| 2022-05-12 | 65 | 80.01 | 81.18 | 61.5791 | 3,364,058 |
| 2022-05-11 | 81.79 | 78.08 | 84.89 | 75.75 | 995,467 |
| 2022-05-10 | 82.44 | 82.64 | 87.35 | 79.43 | 840,504 |
| 2022-05-09 | 81.68 | 78.9 | 83.08 | 75.7 | 818,881 |
| 2022-05-06 | 90.06 | 83.08 | 91.57 | 82.2 | 895,702 |
| 2022-05-05 | 93.07 | 90.22 | 94.31 | 88.83 | 401,879 |
| 2022-05-04 | 91.93 | 94.22 | 94.6 | 88.07 | 565,403 |
| 2022-05-03 | 91.01 | 92.1 | 93.64 | 89.76 | 271,545 |
| 2022-05-02 | 90.82 | 91.05 | 95.76 | 89.76 | 484,687 |
News, Short Squeeze, Breakout and More Instantly...
-
- Joe Kelly has been appointed to the newly created role of Head of U.S. Commercial, Endocrinology - Scott A. Holmes has been appointed to the newly created role of Head of Global Commercial Strategy, Endocrinology - Jesper Høiland, Global Chief Comm...
-
- VISEN’s Phase 3 Trial achieved primary endpoint; pediatric growth hormone deficiency (GHD) patients treated with TransCon™ hGH demonstrated greater annualized height velocity at 52-weeks (p=0.0010) compared to patients treated with daily growth hormone ...
-
Shares of Ascendis Pharma (NASDAQ: ASND) were down by 10.5% as of 12:10 p.m. ET Thursday. The decline came after the drugmaker announced its first-quarter results following the market close on Wednesday. The Denmark-based multinational reported Q1 revenue of 6.8 million euros, a...